1. Home
  2. CLSD vs VVPR Comparison

CLSD vs VVPR Comparison

Compare CLSD & VVPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSD
  • VVPR
  • Stock Information
  • Founded
  • CLSD 2011
  • VVPR 2014
  • Country
  • CLSD United States
  • VVPR United Kingdom
  • Employees
  • CLSD N/A
  • VVPR N/A
  • Industry
  • CLSD Biotechnology: Pharmaceutical Preparations
  • VVPR Power Generation
  • Sector
  • CLSD Health Care
  • VVPR Utilities
  • Exchange
  • CLSD Nasdaq
  • VVPR Nasdaq
  • Market Cap
  • CLSD 68.4M
  • VVPR 62.7M
  • IPO Year
  • CLSD 2016
  • VVPR 2016
  • Fundamental
  • Price
  • CLSD $0.42
  • VVPR $6.33
  • Analyst Decision
  • CLSD Hold
  • VVPR
  • Analyst Count
  • CLSD 4
  • VVPR 0
  • Target Price
  • CLSD $4.33
  • VVPR N/A
  • AVG Volume (30 Days)
  • CLSD 12.9M
  • VVPR 2.3M
  • Earning Date
  • CLSD 08-08-2025
  • VVPR 01-01-0001
  • Dividend Yield
  • CLSD N/A
  • VVPR N/A
  • EPS Growth
  • CLSD N/A
  • VVPR N/A
  • EPS
  • CLSD N/A
  • VVPR N/A
  • Revenue
  • CLSD $4,166,000.00
  • VVPR $79,000.00
  • Revenue This Year
  • CLSD $78.37
  • VVPR N/A
  • Revenue Next Year
  • CLSD $17.79
  • VVPR N/A
  • P/E Ratio
  • CLSD N/A
  • VVPR N/A
  • Revenue Growth
  • CLSD N/A
  • VVPR N/A
  • 52 Week Low
  • CLSD $0.29
  • VVPR $0.62
  • 52 Week High
  • CLSD $1.65
  • VVPR $8.88
  • Technical
  • Relative Strength Index (RSI)
  • CLSD 39.95
  • VVPR 60.71
  • Support Level
  • CLSD $0.40
  • VVPR $3.60
  • Resistance Level
  • CLSD $0.47
  • VVPR $6.98
  • Average True Range (ATR)
  • CLSD 0.06
  • VVPR 0.66
  • MACD
  • CLSD 0.01
  • VVPR 0.21
  • Stochastic Oscillator
  • CLSD 26.87
  • VVPR 80.77

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

About VVPR VivoPower International PLC

Vivopower International PLC is a solar power company. It provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions, Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Electric Vehicles segment. Geographically its key revenue derives from the Netherlands.

Share on Social Networks: